From March 10, 2022 to September 8, 2022, the company has repurchased 118,321 shares, representing 0.65% for KRW 2,859.89 million. With this, the company has completed the repurchase of 118,321 shares, representing 0.65% for KRW 2,859.89 million under the buyback announced on March 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,710 KRW | +0.22% | -1.01% | -12.40% |
1st Jan change | Capi. | |
---|---|---|
-12.40% | 179M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A007570 Stock
- News Ilyang Pharmaceutical Co.,Ltd
- Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.